A drug for diabetes-related kidney disease could be repurposed to restore fertility for women affected by premature ovarian insufficiency, a largely untreatable condition, according to a study by Hong Kong researchers.
The study, conducted by scholars from the University of Hong Kong’s faculty of medicine, found that finerenone – a drug used to treat type 2 diabetes-related chronic kidney disease – could be used to awaken dormant small follicles in women and promote the development of follicles…